Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Takeda’s Alogliptin Strategy: Treatment Options

Jun 10 2008

Related Content

Bristol-Myers Squibb Targets Mid-year Filing For Saxagliptin

Jun 06 2008

Industry Eyes DPP-4, GLP-1 Data From Diabetes Meeting

Jun 05 2008

Takeda Files DPP-4 Inhibitor NDA, Poised To Best Bristol/AstraZeneca, Novartis In Race For Second To Market

Jan 04 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window